Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04546724
Recruitment Status : Completed
First Posted : September 14, 2020
Last Update Posted : December 22, 2021
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 19, 2021
Actual Study Completion Date : October 14, 2021